Alligator Bioscience AB (publ) Profit Margin

The latest profit margin for ATORX.ST is -29011.31% as of September 2026. That compares with -163.57% in the prior-year period — down 17636.7% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Alligator Bioscience AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ATORX.ST's profit margin moved from -163.57% to -29011.31% — a 17636.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Alligator Bioscience AB (publ)'s valuation or profitability profile.

Against Healthcare companies, ATORX.ST currently prints -29011.31% for profit margin, while the sector average sits near 9.48%. That is roughly 306095.4% below the sector mean. Large gaps often invite a closer look at Alligator Bioscience AB (publ)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Alligator Bioscience AB (publ) converts resources into returns. At -29011.31%, ATORX.ST may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -163.57% in the prior-year period — down 17636.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ATORX.ST's profit margin (-29011.31%), review year-over-year change from -163.57%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.